Innospec Inc. — Earnings Quality Grade C
IOSP · Basic Materials
Some red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 70 days, change +3 days YoY
AR outpaced revenue for 2 consecutive years
Revenue -3.7%, CFFO -25.0%. Cash follows revenue
Expense Quality
Inventory 9.4% vs COGS -1.3%. Normal
CapEx growth 21.2% is >2x revenue growth -3.7%
SG&A/Gross Profit = 57.9%. Normal
Gross margin 27.7%, change -1.7pp. Stable
Cash Flow Quality
CFFO/NI = 1.19. Profits backed by cash
FCF $0.1B, FCF/NI = 0.54
Accruals ratio = -1.2%. Low accruals
Cash $0.3B covers debt $0.1B
Balance Sheet Health
Goodwill+Intangibles $0.5B = 35% of equity
Debt/EBITDA = 0.3x. Healthy
Other assets grew 123.1% vs revenue -3.7%
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change 4% YoY. Normal
Manipulation Score
M-Score = -2.46 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor IOSP continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25